UPLOAD Filing
Enlivex Ltd.
Date: May 7, 2025 · CIK: 0001596812 · Accession: 0000000000-25-004841
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286956
Letter
Re: Enlivex Therapeutics Ltd. Registration Statement on Form F-3 Filed May 2, 2025 File No. 333-286956 Dear Oren Hershkovitz:
May 7, 2025
Oren Hershkovitz Chief Executive Officer Enlivex Therapeutics Ltd. 14 Einstein Street Ness Ziona Israel 7403618
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Win Rutherfurd, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> May 7, 2025 Oren Hershkovitz Chief Executive Officer Enlivex Therapeutics Ltd. 14 Einstein Street Ness Ziona Israel 7403618 Re: Enlivex Therapeutics Ltd. Registration Statement on Form F-3 Filed May 2, 2025 File No. 333-286956 Dear Oren Hershkovitz: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Win Rutherfurd, Esq. </TEXT> </DOCUMENT>